Hawaii lawmakers introduced several workers’ comp bills focused on controlling pharmacy costs, improving regulatory clarity, and reducing delays in medical treatment for injured workers.

House Bill 1648 would add new language prohibiting providers from prescribing or dispensing nonprescription, over‑the‑counter, and non‑legend drugs to injured workers. Lawmakers say unclear reimbursement rules have contributed to inflated charges and higher workers’ compensation costs. The bill is awaiting committee assignment and, if enacted, would take effect July 1, 2026.

Senate Bill 2751 would add the federal definition of “compounded drug” to align Hawaii’s workers’ compensation laws with federal standards. Legislators say inconsistent definitions have created confusion, and adopting a uniform framework would improve patient safety and regulatory consistency. If enacted, it would take effect July 1, 2026.

Senate Bill 2663 would require employers to approve or deny medical treatment plans within seven days. Although current law deems a plan accepted if no objection is filed, physicians often hesitate to begin care without timely written confirmation.

The bill places the burden on employers to support denials with medical evidence, presumes unsupported denials to be unreasonable, prohibits withholding payment for authorized care while disputes are pending, and establishes penalties of $250 per day for untimely responses and at least $1,000 for unreasonable or frivolous denials. If enacted, it would take effect upon approval.

These measures target pharmacy management and medication oversight and could alter how employers and insurers approve treatment. Together, the bills reflect Hawaii lawmakers’ renewed commitment to tackling persistent workers’ comp issues such as escalating medication costs, variable pharmacy practices, and barriers to prompt access to care.